Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK and Safety of CJ-30056 vs Co-administration in Fed Healthy Males
NCT02378441Phase 1Completed
- Sponsor
- HK inno.N Corporation
- Start
- Feb 2015
- Primary completion
- Mar 2015
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of atorvastatin + metformin in type 2 diabetes mellitus (T2DM) and hypercholesterolemia (2 arms), sponsored by HK inno.N Corporation. Primary endpoint: Maximum Plasma Concentration at 32 hours. Started Feb 2015; status: completed.
02
Drugs
atorvastatin + metformin
03
Conditions
type 2 diabetes mellitus (T2DM)hypercholesterolemia
Beyond the preview
Go deeper on NCT02378441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02378441.